A world leader in nuclear medicine
ANSTO is central to Australia’s nuclear medicine manufacturing capabilities. Each week ANSTO delivers 10,000 patient doses of potentially lifesaving nuclear medicines to over 250 hospitals and medical practices across Australia.
Nuclear medicines are used to diagnose a wide range of illnesses including cardiac conditions, cancers and skeletal injuries. It is estimated one in two Australians will benefit from the nuclear medicines that originate from ANSTO.
With the ANM project Australia will triple its production of this vital medicine used in research and diagnosis for the benefit of not only Australians, but the rest of the world.